Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Gottex reveals assets down but returns up over quarter to end June

Tuesday, July 23, 2013
Opalesque Industry Update - Gottex Fund Management announced its trading statement for the quarter ended 30 June 2013.

Highlights included:

  • The flagship fund of hedge funds products continue to perform well and post positive returns 2013 year to date. Exceptional performance by Asian strategies, up 7.9%, alternative credit strategies up 4.2% and portable alpha US equity strategies up 16.2% year to date.
  • Total fee-earning assets for the group decreased by 6.5% to USD 5.941 billion compared to USD 6.36 billion at 31 March 2013, as a result of net outflows and foreign exchange impact.
  • After the more challenging global performance environment towards the end of Q2, Gottex’s second market neutral product is now expected to regain its high water mark in Q3 2013 and will then start accruing performance fees.
  • Completion of the acquisition of a majority holding in UK-based Frontier Investment Management, allowing the group to offer liquid onshore multi-asset products.
  • Completion of joint venture with partners of Australian based consulting firm Zenith offering hedge fund advisory services to local institutional investors.
  • The company expects the 2013 interim results to show a small cash operating loss (subject to audit and final review).
  • Edex, our hedge fund workout service which manages over USD 600 million, won a major third party mandate to take over a hedge fund portfolio of USD 140 million.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its